Alcon Inc.

NYSE:ALC

Medical - Instruments & Supplies

Healthcare
$75.26 +0.94%

+$0.61 today

Market cap
$36.15B
Beta
0.70
P/E (TTM)
38.7
EPS (TTM)
$1.67
Dividend yield
0.55%
52W Low $61.84High $92.55

Volume 4.74M

Average 1.91M

ALC Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Alcon Inc.NYSE: ALC

Revenue · Q3 FY2026 · quarter ended Sep 2026

Revenue grows, but more slowly than its trailing trend

Q3 FY2026 revenue of $2.74B rose 4.7% year over year, behind the +7.3% change in trailing-twelve-month revenue. Sequentially, it fell 3.0% from the prior quarter. Over 3 fiscal years it compounded at +6.1% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 12 analysts of $10.93B (+5.1%) for the fiscal year ending Dec 2026, a pace similar to FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$2.74B-3.0% QoQ
Last fiscal yearDec 2025
$10.4B+4.9% YoY
LTMSep 2026
$10.93B+7.3% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.7%+3.4%-1.3 pp
1 year+4.9%+5.1%+0.2 pp
3-year CAGR+6.1%+5.6%-0.5 pp
5-year CAGR+5.6%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
10.4B USD
Year-over-year change
+4.9%
4-year CAGR
+5.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How ALC compares with its peers on the latest reported figures

  • ALC's LTM Sep 2026 revenue of $10.93B is the highest of the 8 companies compared; the peer median is $290.38M.
  • Its year-over-year change of +7.3% is the 3rd highest of 8, against a peer median of +4.0%.
  • Over three fiscal years its annual growth of +6.1% compares with a peer median of +10.6%.
ALC Competitors Peer median
Revenue for ALC and competitors
Company Period LTM YoY 3-year CAGR
ALCAlcon Inc.LTM Sep 2026$10.93B +7.3%+6.1%
BLCOBausch + Lomb CorporationLTM Jun 2026$5.32B +8.8%+10.6%
COOThe Cooper Companies, Inc.LTM Jul 2026$4.24B +4.7%+7.3%
GKOSGlaukos CorporationLTM Jun 2026$612.84M +41.5%+21.5%
STAASTAAR Surgical CompanyLTM Apr 2026$290.38M +4.0%-5.6%
RXSTRxSight, Inc.LTM Mar 2026$127.48M -19.5%+40.0%
SGHTSight Sciences, Inc.LTM Mar 2026$79.55M +1.8%+2.7%
LNSRLENSAR, Inc.LTM Mar 2026$57.7M +1.1%+18.2%
Peer median (excluding ALC) $290.38M+4.0%+10.6%

Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.29B8.72B9.46B9.91B10.4B
Cost of Revenue3.64B3.97B4.21B4.4B4.66B
Gross Profit4.65B4.75B5.25B5.51B5.75B
Gross Margin56.1%54.5%55.5%55.6%55.2%
Research & Development842M702M859M876M990M
Selling, General & Admin3.08B3.07B3.21B3.25B3.45B
Operating Expenses4.07B4.08B4.21B4.1B4.39B
Depreciation & Amortization1.22B1.12B1.22B1.23B1.34B
EBITDA1.76B1.74B2.24B2.68B2.5B
EBITDA Margin21.2%20.0%23.7%27.0%24.0%
Operating Income580M672M1.04B1.41B1.36B
Operating Margin7.0%7.7%11.0%14.3%13.1%
Interest Income3.01M16.52M34M81.45M74M
Interest Expense120.26M138.4M189M186.18M204M
Other Income / Expenses(162M)(209M)(207M)(157M)(200M)
Income Before Tax418M463M832M1.26B1.16B
Pre-Tax Margin5.0%5.3%8.8%12.7%11.2%
Income Tax Expense42M128M(142M)238M180M
Net Income376M335M974M1.02B980M
Net Margin4.5%3.8%10.3%10.3%9.4%
EPS (Basic)0.770.681.982.061.99
EPS (Diluted)0.760.681.962.051.98
Weighted Avg Shares490M491.4M493M494.4M494.95M
Weighted Avg Shares (Diluted)493.4M494.4M496.5M497.5M496.2M

Alcon Inc.

NYSE:ALC

Intrinsic Alpha fair value

Locked

Current Price

$75.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.